These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25681413)

  • 21. Screening of CHCHD10 in a French cohort confirms the involvement of this gene in frontotemporal dementia with amyotrophic lateral sclerosis patients.
    Chaussenot A; Le Ber I; Ait-El-Mkadem S; Camuzat A; de Septenville A; Bannwarth S; Genin EC; Serre V; Augé G; ; Brice A; Pouget J; Paquis-Flucklinger V
    Neurobiol Aging; 2014 Dec; 35(12):2884.e1-2884.e4. PubMed ID: 25155093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CHCHD10 mutations induce tissue-specific mitochondrial DNA deletions with a distinct signature.
    Shammas MK; Nie Y; Gilsrud A; Huang X; Narendra DP; Chinnery PF
    Hum Mol Genet; 2023 Dec; 33(1):91-101. PubMed ID: 37815936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the CHCHD10 gene in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Spain.
    Dols-Icardo O; Nebot I; Gorostidi A; Ortega-Cubero S; Hernández I; Rojas-García R; García-Redondo A; Povedano M; Lladó A; Álvarez V; Sánchez-Juan P; Pardo J; Jericó I; Vázquez-Costa J; Sevilla T; Cardona F; Indakoechea B; Moreno F; Fernández-Torrón R; Muñoz-Llahuna L; Moreno-Grau S; Rosende-Roca M; Vela Á; Muñoz-Blanco JL; Combarros O; Coto E; Alcolea D; Fortea J; Lleó A; Sánchez-Valle R; Esteban-Pérez J; Ruiz A; Pastor P; López De Munain A; Pérez-Tur J; Clarimón J;
    Brain; 2015 Dec; 138(Pt 12):e400. PubMed ID: 26152333
    [No Abstract]   [Full Text] [Related]  

  • 24. Genetic analysis of CHCHD10 in French familial amyotrophic lateral sclerosis patients.
    Teyssou E; Chartier L; Albert M; Bouscary A; Antoine JC; Camdessanché JP; Rotolo F; Couratier P; Salachas F; Seilhean D; Millecamps S
    Neurobiol Aging; 2016 Jun; 42():218.e1-3. PubMed ID: 27095681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CHCHD2 accumulates in distressed mitochondria and facilitates oligomerization of CHCHD10.
    Huang X; Wu BP; Nguyen D; Liu YT; Marani M; Hench J; Bénit P; Kozjak-Pavlovic V; Rustin P; Frank S; Narendra DP
    Hum Mol Genet; 2018 Nov; 27(22):3881-3900. PubMed ID: 30084972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CHCHD10 mutations promote loss of mitochondrial cristae junctions with impaired mitochondrial genome maintenance and inhibition of apoptosis.
    Genin EC; Plutino M; Bannwarth S; Villa E; Cisneros-Barroso E; Roy M; Ortega-Vila B; Fragaki K; Lespinasse F; Pinero-Martos E; Augé G; Moore D; Burté F; Lacas-Gervais S; Kageyama Y; Itoh K; Yu-Wai-Man P; Sesaki H; Ricci JE; Vives-Bauza C; Paquis-Flucklinger V
    EMBO Mol Med; 2016 Jan; 8(1):58-72. PubMed ID: 26666268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CHCHD10 Pro34Ser is not a highly penetrant pathogenic variant for amyotrophic lateral sclerosis and frontotemporal dementia.
    Abdelkarim S; Morgan S; Plagnol V; Lu CH; Adamson G; Howard R; Malaspina A; Orrell R; Sharma N; Sidle K; Clarke J; Fox NC; Rossor MN; Warren JD; Clark CN; Rohrer JD; Fisher EM; Mead S; Pittman A; Fratta P
    Brain; 2016 Feb; 139(Pt 2):e9. PubMed ID: 26362910
    [No Abstract]   [Full Text] [Related]  

  • 28. CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients.
    Chiò A; Mora G; Sabatelli M; Caponnetto C; Traynor BJ; Johnson JO; Nalls MA; Calvo A; Moglia C; Borghero G; Monsurrò MR; La Bella V; Volanti P; Simone I; Salvi F; Logullo FO; Nilo R; Battistini S; Mandrioli J; Tanel R; Murru MR; Mandich P; Zollino M; Conforti FL; ; Brunetti M; Barberis M; Restagno G; Penco S; Lunetta C
    Neurobiol Aging; 2015 Apr; 36(4):1767.e3-1767.e6. PubMed ID: 25726362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CHCHD10 and SLP2 control the stability of the PHB complex: a key factor for motor neuron viability.
    Genin EC; Bannwarth S; Ropert B; Lespinasse F; Mauri-Crouzet A; Augé G; Fragaki K; Cochaud C; Donnarumma E; Lacas-Gervais S; Wai T; Paquis-Flucklinger V
    Brain; 2022 Oct; 145(10):3415-3430. PubMed ID: 35656794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of mitochondrial disease with multiple mitochondrial DNA deletions suspected amyotrophic lateral sclerosis-frontotemporal dementia].
    Ishikawa T; Nakamura K; Shimasaki R; Goto K; Umehara F
    Rinsho Shinkeigaku; 2018 Jan; 58(1):15-20. PubMed ID: 29269692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of function CHCHD10 mutations in cytoplasmic TDP-43 accumulation and synaptic integrity.
    Woo JA; Liu T; Trotter C; Fang CC; De Narvaez E; LePochat P; Maslar D; Bukhari A; Zhao X; Deonarine A; Westerheide SD; Kang DE
    Nat Commun; 2017 Jun; 8():15558. PubMed ID: 28585542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frontotemporal Dementia-Related V57E Mutation Impairs Mitochondrial Function and Alters the Structural Properties of CHCHD10.
    Alici H; Uversky VN; Liu T; Kang DE; Woo JA; Coskuner-Weber O
    ACS Chem Neurosci; 2023 Jun; 14(11):2134-2145. PubMed ID: 37194187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitochondrial pathobiology in Parkinson's disease and amyotrophic lateral sclerosis.
    Martin LJ
    J Alzheimers Dis; 2010; 20 Suppl 2():S335-56. PubMed ID: 20413846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of CHCHD2 and CHCHD10 activates OMA1 peptidase to disrupt mitochondrial cristae phenocopying patient mutations.
    Liu YT; Huang X; Nguyen D; Shammas MK; Wu BP; Dombi E; Springer DA; Poulton J; Sekine S; Narendra DP
    Hum Mol Genet; 2020 Jun; 29(9):1547-1567. PubMed ID: 32338760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients.
    Perrone F; Nguyen HP; Van Mossevelde S; Moisse M; Sieben A; Santens P; De Bleecker J; Vandenbulcke M; Engelborghs S; Baets J; Cras P; Vandenberghe R; De Jonghe P; De Deyn PP; Martin JJ; Van Damme P; Van Broeckhoven C; van der Zee J;
    Neurobiol Aging; 2017 Mar; 51():177.e9-177.e16. PubMed ID: 28069311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondria in amyotrophic lateral sclerosis: a trigger and a target.
    Dupuis L; Gonzalez de Aguilar JL; Oudart H; de Tapia M; Barbeito L; Loeffler JP
    Neurodegener Dis; 2004; 1(6):245-54. PubMed ID: 16908975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of CHCHD10-CHCHD2 complexes required for respiration underlies the pathogenicity of a CHCHD10 mutation in ALS.
    Straub IR; Janer A; Weraarpachai W; Zinman L; Robertson J; Rogaeva E; Shoubridge EA
    Hum Mol Genet; 2018 Jan; 27(1):178-189. PubMed ID: 29121267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial disfunction as a cause of ALS.
    Pizzuti A; Petrucci S
    Arch Ital Biol; 2011 Mar; 149(1):113-9. PubMed ID: 21412720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial mutations: genotype to phenotype.
    Schon EA; DiMauro S
    Novartis Found Symp; 2007; 287():214-25; discussion 226-33. PubMed ID: 18074641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction.
    Zhou W; Ma D; Sun AX; Tran HD; Ma DL; Singh BK; Zhou J; Zhang J; Wang D; Zhao Y; Yen PM; Goh E; Tan EK
    Hum Mol Genet; 2019 Apr; 28(7):1100-1116. PubMed ID: 30496485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.